Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

STAT June 8, 2023
Damian Garde and Meg Tirrell and Adam Feuerstein

Are drug prices protected by the Constitution? Will Medicare embrace Alzheimer’s disease treatments? And should lawyers be allowed to use thesauruses?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT Washington correspondent Rachel Cohrs joins us to explain Merck’s lawsuit against the federal government and why the company believes drug pricing negotiation is “tantamount to extortion.” We also discuss the health effects of Canadian wildfires, the highlights of the year’s biggest cancer research conference, and what could be...

Today's Sponsors

Today's Sponsor